NOUVELLES

Guest User 10/24/24 Guest User 10/24/24

Epitopea conclut des ententes de financement préalable à la série A d’un montant de 31 millions de dollars US

Epitopea conclut des ententes de financement préalable à la série A d’un montant de 31 millions de dollars US

Read More

Guest User 10/21/24 Guest User 10/21/24

Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101

Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101

Read More

Guest User 7/15/24 Guest User 7/15/24

AstraZeneca Closes Acquisition of Amolyt Pharma

AstraZeneca Closes Acquisition of Amolyt Pharma

Read More

Guest User 3/14/24 Guest User 3/14/24

Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca

Read More

Guest User 3/11/24 Guest User 3/11/24

AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b

AbilityPharma Announces € 7 Million Financing Round to Advance Development of its Clinical Phase 2b

Read More